New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2013
16:31 EDTTRV, ARNA, RIMM, BOX, MSFT, DELL, VZ, DD, JNJ, IIVIOn The Fly: Closing Wrap
Stocks on Wall Street were slightly higher after four Dow components reported mixed quarterly results before the bell. The earnings calendar is fairly heavy again after the bell, as investors receive results from tech giants Google (GOOG) and International Business Machines (IBM) among those reporting... ECONOMIC EVENTS: In the U.S., sales of existing homes unexpectedly dropped 1% in December to a 4.94M annual rate, versus expectations for sales to increase to a 5.1M rate. Two regional Fed surveys were also reported, with the Chicago Fed National Activity Index slipping but remaining positive at 0.02, while the Richmond Fed Manufacturing Survey plunged 17 points to -12... COMPANY NEWS: Among the four Dow members reporting results, Travelers (TRV) was the leader, gaining $1.64, or 2.15%, to $77.95 after its better than expected earnings. Shares of DuPont (DD) and Verizon (VZ) were also higher. Johnson & Johnson (JNJ) slid 54c, or 0.74%, to $72.69 after its quarterly report in spite of announcing plans to explore options for its Ortho Clinical Diagnostics unit, including a potential sale or spin-off... Microsoft (MSFT) is in talks to invest between $1B-$3B as part of a leveraged buyout of Dell (DELL), according to CNBC's David Faber. Dell spiked higher following the news, finishing up 28c, or 2.18%, at $13.12, while Microsoft lost 8c, or 0.29%, to $27.17... MAJOR MOVERS: Among the notable gainers was SeaCube (BOX), up $2.84, or 13.99%, to $23.14 after agreeing to be acquired by Ontario Teachers' Pension for $23 per share. Also higher were shares of Research In Motion (RIMM), which rose $2.06, or 13.01%, to $17.90 after its CEO reportedly said it may license the BB10 operating system and shares were upgraded to Outperform at Scotia Capital with a $23 price target. Among the noteworthy losers was Arena Pharmaceuticals (ARNA), which lost 95c, or 9.72%, to $8.82 after the European Medicines Agency asked it to address issues with its anti-obesity drug. Also lower were shares of II-VI (IIVI), down $1.87, or 9.51%, to $17.80 after the company's Q2 report fell short of expectations and its FY13 guidance came in below Street estimates... INDICES: The Dow was up 62.43, or 0.46%, to 13,712.13; the Nasdaq was up 8.47, or 0.27%, to 3,143.18; and the S&P 500 was up 6.53, or 0.44%, to 1,492.51.
News For TRV;JNJ;DD;VZ;DELL;MSFT;BOX;RIMM;ARNA;IIVI From The Last 14 Days
Check below for free stories on TRV;JNJ;DD;VZ;DELL;MSFT;BOX;RIMM;ARNA;IIVI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
July 15, 2014
07:47 EDTJNJJohnson & Johnson reports Q2 Domestic sales up 14.9% to $9.13B
Subscribe for More Information
07:46 EDTJNJJohnson & Johnson reports Q2 EPS excluding items $1.66, consensus $1.55
Subscribe for More Information
07:24 EDTMSFTMicrosoft to hold a conference
MSFT Worldwide Partner Conference to be held in Washington, D.C. on July 13-17.
07:23 EDTMSFTFortune to hold a conference
Subscribe for More Information
06:24 EDTMSFTMicrosoft poised to make job reductions, Bloomberg says
Subscribe for More Information
06:06 EDTMSFTElectronic Arts names Ken Moss as Chief Technology Officer
Electronic Arts (EA) announced on its website that it has named Ken Moss as its Chief Technology Officer. As CTO, Ken will lead the organization, strategy and vision for EA’s Digital Platform and Information Technology divisions. Moss comes to EA most recently from eBay (EBAY), where he led the Marketplace Technology, Science and Data global organization. He is a 20-year veteran of Microsoft (MSFT), where he founded and led the engineering and product teams on Search -- which later became Bing -- and played an important role in Microsoft’s transition to large-scale services. Reference Link
July 14, 2014
15:24 EDTJNJNotable companies reporting before tomorrow's open
Subscribe for More Information
15:19 EDTJNJ Johnson & Johnson July 105 straddle priced for 1.6% move into Q2
14:27 EDTJNJEarnings Preview: J&J pharmaceutical sales expected to drive Q2
Johnson & Johnson (JNJ) is scheduled to report second quarter earnings before the market open on Tuesday, July 15, with a conference call scheduled for 8:30 am ET. Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. EXPECTATIONS: Analysts are looking for earnings per share of $1.55 on revenue of $18.94B, according to First Call. The consensus range for EPS is $1.45-$1.61 on revenue of $18.55B-$19.30B. LAST QUARTER: Johnson & Johnson reported first quarter EPS of $1.54 against estimates of $1.48 on revenue of $18.1B against estimates of $18B. The drug maker raised its fiscal year EPS view to $5.80-$5.90 against a consensus estimate of $5.83. J&J noted a 3.2% decrease in worldwide consumer sales in Q1 but saw a 10.8% increase in worldwide pharmaceutical sales. Primary contributors to operational sales growth in Q1 pharmaceutical sales were Stelara, Invega, Sustenna/Xeplion, Prezista, Velcade and sales of new products. Pharmaceutical sales results were negatively impacted by loss of exclusivity for Aciphex, a proton pump inhibitor for gastrointestinal disorders and Concerta for the treatment of attention deficit hyperactivity disorder. STREET RESEARCH: On July 14, RBC Capital raised its Q2 estimates for Johnson & Johnson to reflect the firm's outlook for higher pharmaceutical sales by the company. The firm raised its price target on the shares to $110 from $106 and kept an Outperform rating on the stock. PRICE ACTION: Shares of Johnson & Johnson are up approximately 8.5% since its last earnings report, and are trading near flat in afternoon trading.
12:24 EDTJNJJohnson & Johnson technical notes before earnings
The company is scheduled to report before market open on July 15th. The shares in the prior three months have risen by more than 8%, anticipating positive news for the current and forthcoming quarters. At the current price of $105.39, the only remaining established resistance on the daily chart is at the life high of $106.74. If the news and guidance is better than expected, a run to $110, or $115 at an extreme, would be possible. If the news fails to meet expectations or guidance is weak, support would be at $102.70, the 50-day moving average. A break below this uptrend support proxy would be a sell signal in many technical trading systems and would break an uptrend in place since early March of this year. On a sliding scale of increasingly weaker news, supports would next be at $99.96, and then at $96.87.
08:46 EDTMSFTItron selects Microsoft Azure as preferred cloud platform
Subscribe for More Information
08:34 EDTMSFTPC market stability could be short-lived, Reuters says
Subscribe for More Information
08:30 EDTJNJJohnson & Johnson should be bought on any weakness, says RBC Capital
Subscribe for More Information
07:48 EDTMSFTQuantum computer company D-Wave may come public, FT says
Subscribe for More Information
06:08 EDTMSFTMicrosoft confirms plans to discontinue MapPoint, Streets & Tips
Subscribe for More Information
06:05 EDTMSFTMicrosoft to expand coverage of free Windows licensing, DigiTimes reports
Subscribe for More Information
July 11, 2014
16:46 EDTVZStocks end week lower on European, Fed concerns
Subscribe for More Information
11:57 EDTMSFTMicrosoft acquires InMage, terms not disclosed
Subscribe for More Information
07:36 EDTJNJJohnson & Johnson Q2 EPS likely to exceed expectations, says Bernstein
Subscribe for More Information
07:21 EDTVZVerizon Q2 postpaid net adds better than expected, says JPMorgan
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use